How many employees does Axcella have?

Axcella has approximately 13 employees.

Where is Axcella headquartered?

The company is based in Cambridge, Massachusetts, United States.

What industry is Axcella in?

Axcella operates in Biotechnology.

Is Axcella still active?

Yes, Axcella was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to Axcella?

Research Axcella's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

Axcella

Biotechnology

Cambridge, United States

13 employees

Founded 2008

axcellatx.com

Verified active February 2, 2026

Key Highlights

Axcella is a clinical-stage biotechnology company focused on treating complex diseases.
They pioneer a new therapeutic approach using endogenous metabolic modulator (EMM) compositions.
The company develops targeted therapeutics for infectious and metabolic disorders.
Axcella's product pipeline includes promising candidates like AXA1665 and AXA1125.
Their innovative strategy aims to address challenging diseases through metabolic modulation.

About Axcella

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. It operates as a developer of targeted therapeutics for infectious and metabolic disorders, with a product pipeline including AXA1665 and AXA1125.

Company Facts

Ownership Private Company

Stock AXLA (Nasdaq)

Funding $191M

Why Contact Axcella?

Axcella is a clinical-stage biotechnology company that develops targeted therapeutics for infectious and metabolic disorders using endogenous metabolic modulator (EMM) compositions.

Who Should Contact Axcella for Business?

Clinical-stage biotechnology company focused on the research and development of therapeutics using endogenous metabolic modulator (EMM) compositions.

More Biotechnology Companies

Biotis Pharmaceuticals Indonesia

Charles River Laboratories

14.8K employees

View all Biotechnology companies

Frequently Asked Questions

What does Axcella do?: Axcella is a clinical-stage biotechnology company that develops targeted therapeutics for infectious and metabolic disorders using endogenous metabolic modulator (EMM) compositions.
How many employees does Axcella have?: Axcella has approximately 13 employees.
Where is Axcella headquartered?: The company is based in Cambridge, Massachusetts, United States.
What industry is Axcella in?: Axcella operates in Biotechnology.
When was Axcella founded?: Axcella was founded in 2008.
Is Axcella still active?: Yes, Axcella was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to Axcella?: Research Axcella's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.